1 |
Ho CM, Lam KH, Wei W et al : Occult lymph node metastasis in small oral tongue cancers. Head Neck 14 : 359, 1992
DOI
ScienceOn
|
2 |
Hannen EJ, Riediger D : The quantification of angiogenesis in relation to metastasis in oral cancer: a review. Int J Oral Maxillofac Surg 33(1) : 2, 2004
DOI
ScienceOn
|
3 |
Fidler IJ, Ellis LM : The implications of angiogenesis for the biology and therapy of cancer metastasis. Cell 79 : 185, 1994
DOI
ScienceOn
|
4 |
Rajesh V, David S, Jeffery D et al : Expression of vascular endothelial growth factor receptors on tumor cells in head and neck squamous cell carcinoma. Arch Otolaryn Head Neck Surg 129 : 882, 2003
DOI
ScienceOn
|
5 |
Ullrich A, Schlessinger J : Signal transduction by receptors with tyrosine kinase activity. Cell 61 : 203, 1990
DOI
ScienceOn
|
6 |
Magkou C, Nakopoulou L, Zoubouli C et al : Expression of the epidermal growth factor receptor (EGFR) and the phosphorylated EGFR in invasive breast carcinomas. Breast Cancer Res 10(3) : R49, 2007
|
7 |
Park YW, In YS : Immunohistochemical assays for the expression of angiogenic signaling molecules and microvessel density in adenoid cystic carcinomas of human salivary glands. J Kor Assoc Oral Maxillofac Surg 32 : 530, 2006
과학기술학회마을
|
8 |
Bei R, Budillon A, Masuelli L et al : Frequent overexpression of multiple ErbB receptors by head and neck squamous cell carcinoma contrasts with rare antibody immunity in patients. Journal of Pathology, 204 : 317, 2004
DOI
ScienceOn
|
9 |
Abu-Ali S, Fotovati A, Shirasuna K : Tyrosine-kinase inhibition results in EGFR clustering at focal adhesions and consequent exocytosis in uPAR down-regulated cells of head and neck cancers. Mol Cancer 7 : 47, 2008
DOI
ScienceOn
|
10 |
Kim S, Park YW, Schiff BA et al : An orthotopic model of anaplastic thyroid carcinoma in athymic nude mice. Clin Cancer Res 8 : 293, 2002
PUBMED
|
11 |
Moriyama M, Kumagai S, Kawashiri K et al : Immunohistochemical study of tumour angiogenesis in oral squamous cell carcinoma. Oral Oncol 33(5) : 369, 1997
DOI
ScienceOn
|
12 |
Breiteneder-Geleff S, Soleiman A, Kowalski H et al : Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: podoplanin as a specific marker for lymphatic endothelium. Am J Pathol 154 : 385, 1999
DOI
PUBMED
ScienceOn
|
13 |
Sano D, Myers JN : Metastasis of squamous cell carcinoma of the oral tongue. Cancer Metastasis Rev 26 : 645, 2007
DOI
|
14 |
Park YW, Younes MN, Jasser SA et al : AEE788, a dual tyrosine kinase receptor inhibitor, induces endothelial cell apoptosis in human cutaneous squamous cell carcinoma xenografts in nude mice. Clin Cancer Res 11 : 1963, 2005
DOI
ScienceOn
|
15 |
Park YW, Chung SH : An experimental study for establishment of orthotopic salivary tumor models in mice. J Kor Oral Maxillofac Surg 33(2) : 81, 2007
과학기술학회마을
|
16 |
Sticht C, Freier K, Knopfle K et al : Activation of MAP kinases signaling through ERK5 but not ERK1 expression is associated with lymph node metastases in oral squamous cell carcinoma (OSCC). Neoplasia 10 : 462, 2008
DOI
PUBMED
|
17 |
Maual SM, Luukkaa M, Grenman R et al : Intratumoral lymphatics are essential for the metastatic spread and prognosis in squamous cell carcinomas of the head and neck region. Cancer Res 63 : 1920, 2003
PUBMED
|
18 |
Grandi C, Alloisio M, Moglia D et al : Prognostic significance of lymphatic spread in head and neck carcinomas: Therapeutic implications. Head Neck Surg 8 : 67, 1985
DOI
|
19 |
Stacker SA, Williams RA, Achen MG : Lymphangiogenic growth factors as markers of tumor metastasis. APMIS 112 : 539, 2004
DOI
ScienceOn
|
20 |
Mustonen T, Alitalo K : Endothelial receptor tyrosine kinases involved in angiogenesis. J Cell Biol 129(4) : 895, 1995
DOI
|
21 |
Van Trappen PO, Steele D, Lowe DG et al : Expression of vascular endothelial growth factor (VEGF)-C and VEGFD, and their receptor VEGFR-3, during different stages of cervical carcinogenesis. J Pathol 201 : 544, 2003
DOI
ScienceOn
|
22 |
Rodrigues VC, Moss SM, Tuomainen H : Oral cancer in the UK: To screen or not to screen. Oral Oncol 34 : 454, 1998
DOI
ScienceOn
|
23 |
Lydiatt DD, Robbins KT, Byers RM et al : Treatment of stage I and II oral tongue cancer. Head Neck 15 : 308, 1993
DOI
ScienceOn
|
24 |
Cochran AJ, Morton DL : Management of the ragional lymph nodes in patients with cutaneous malignant melanoma. World J Surg 16 : 214, 1992
DOI
|
25 |
Kowalski LP, Medina JE : Nodal metastasis: predictive factors. Otolaryngol Clin North Am. 31 : 621, 1998
DOI
|
26 |
Silverman S Jr : Demographics and occurrence of oral and pharyngeal cancers. The outcomes, the trends, the challenge. J Am Dent Assoc 132(Suppl) : 7S, 2001
DOI
|
27 |
Folkman J : Angiogenesis in cencer, vascualr, rheumatoid, and other disease. Nature Med 1 : 27, 1995
DOI
|
28 |
Yigitbasi OG, Younes MN, Doan D et al : Tumor cell and endothelial cell therapy of oral cancer by dual tyrosine kinase receptor blockade. Cancer Res 64 : 7977, 2004
DOI
ScienceOn
|
29 |
Myers JN, Holsinger FC, Jasser SA et al : An orthotopic nude mouse model of oral tongue squamous cell carcinoma. Clin Cancer Res 8 : 293, 2002
PUBMED
|
30 |
Neufeld G, Cohen T, Gitay-Goren H : Similarities and differences between the vascular endothelial growth factor (VEGF) splice variants. Cancer Metastasis Rev 15 : 153, 1996
DOI
|
31 |
Ohno F, Nakanishi H, Abe A et al : Regional difference in intratumoral lymphangiogenesis of oral squamous cell carcinomas evaluated by immunohistochemistry using D2-40 and podoplanin antibody: an analysis in comparison with angiogenesis. J Oral Pathol Med 36 : 281, 2001
|
32 |
Shayan R, Achen MG, Stacker SA : Lymphatic vessels in cancer metastasis: bridging the gaps. Carcinogenesis 27(9) : 1729, 2006
DOI
ScienceOn
|
33 |
Sleeman JP : The lymph node as a bridgehead in the metastatic dissemination of tumours. Recent Results Cancer Res 157 : 55, 2000
|
34 |
Ang KK, Berkey BA, Tu X et al : Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma. Cancer Res 62 : 7350, 2002
PUBMED
|
35 |
Parkin DM, Pisani P, Ferlay J : Global cancer statistics. CA. Cancer J Clinicians 49 : 33, 1999
DOI
ScienceOn
|